Treatment resistance and relapse in the most common type of lung cancer can be traced to a protein called agrin, according to ...

Pulmonary sarcoidosis is a lung disease characterized by granulomas—tiny clumps of immune cells that form in response to ...

The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...

Rutgers Health researchers have discovered that networks of misplaced immune cells drive an aggressive lung disease, potentially opening a path to new treatments for a condition that kills 80% of ...

providing critical evidence for expert consensus towards the Healthy China Outline (2030). How about your other ‘firsts’ in cancer research? Lung cancer is a highly heterogeneous disease with ...

"We are collaborating with scientists and physicians at UVA and other institutions to understand the exact function of this understudied organelle in long COVID and other chronic lung diseases ...

Alveolus Bio is pioneering inhaled delivery of live biotherapeutic products (LBPs) to reduce inflammation in patients with lung diseases. Built on science from a top US respiratory center ...